Sciety

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M ^pro inhibitor

This article has 16 authors:
1. Daniel Zaidman
2. Paul Gehrtz
3. Mihajlo Filep
4. Daren Fearon
5. Jaime Prilusky
6. Shirly Duberstein
7. Galit Cohen
8. David Owen
9. Efrat Resnick
10. Claire Strain-Damerell
11. Petra Lukacik
12. Covid-Moonshot Consortium
13. Haim Barr
14. Martin A. Walsh
15. Frank von Delft
16. Nir London
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 22, 2020Latest activity Sep 28, 2020
Fluorescent Glycan Fingerprinting of SARS2 Spike Proteins

This article has 2 authors:
1. Zhengliang L Wu
2. James M Ertelt
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 18, 2021Latest activity Jan 19, 2021
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

This article has 5 authors:
1. Jarrod Shilts
2. Thomas W. M. Crozier
3. Edward J. D. Greenwood
4. Paul J. Lehner
5. Gavin J. Wright
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 11, 2021Latest activity Jul 27, 2020
Structural characterization of cocktail-like targeting polysaccharides from Ecklonia kurome Okam and their anti-SARS-CoV-2 activities invitro

This article has 16 authors:
1. Shihai Zhang
2. Rongjuan Pei
3. Meixia Li
4. Hao Sun
5. Minbo Su
6. Yaqi Ding
7. Xia Chen
8. Zhenyun Du
9. Can Jin
10. Chunfan Huang
11. Yi Zang
12. Jia Li
13. Yechun Xu
14. Xinwen Chen
15. Bo Zhang
16. Kan Ding
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 15, 2021Latest activity Jan 16, 2021
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

This article has 22 authors:
1. Michael Westberg
2. Yichi Su
3. Xinzhi Zou
4. Pinghan Huang
5. Arjun Rustagi
6. Jaishree Garhyan
7. Puja Bhavesh Patel
8. Daniel Fernandez
9. Yan Wu
10. Chenzhou Hao
11. Chieh-Wen Lo
12. Marwah Karim
13. Lin Ning
14. Aimee Beck
15. Panatda Saenkham-Huntsinger
16. Vivian Tat
17. Aleksandra Drelich
18. Bi-Hung Peng
19. Shirit Einav
20. Chien-Te K. Tseng
21. Catherine Blish
22. Michael Z. Lin
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 13, 2024Latest activity Sep 21, 2020
Effect of β-chitosan on the binding interaction between SARS-CoV-2 S-RBD and ACE2

This article has 15 authors:
1. Gulimiran Alitongbieke
2. Xiu-min Li
3. Qi-Ci Wu
4. Zhi-Chao Lin
5. Jia-Fu Huang
6. Yu Xue
7. Jing-Na Liu
8. Jin-Mei Lin
9. Tao Pan
10. Yi-Xuan Chen
11. Yi Su
12. Guo-Guang Zhang
13. Bo Leng
14. Shu-Wen Liu
15. Yu-Tian Pan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 31, 2020Latest activity Aug 2, 2020
Cryo-EM Structures of the SARS-CoV-2 Endoribonuclease Nsp15

This article has 16 authors:
1. Monica C. Pillon
2. Meredith N. Frazier
3. Lucas B. Dillard
4. Jason G. Williams
5. Seda Kocaman
6. Juno M. Krahn
7. Lalith Perera
8. Cassandra K. Hayne
9. Jacob Gordon
10. Zachary D. Stewart
11. Mack Sobhany
12. Leesa J. Deterding
13. Allen L. Hsu
14. Venkata P. Dandey
15. Mario J. Borgnia
16. Robin E. Stanley
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Aug 11, 2020Latest activity Aug 14, 2020
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants

This article has 4 authors:
1. Kui K. Chan
2. Timothy J.C. Tan
3. Krishna K. Narayanan
4. Erik Procko
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 19, 2020Latest activity Oct 22, 2020
Extracellular Vesicles Analysis in the COVID-19 Era: Insights on Serum Inactivation Protocols Towards Downstream Isolation and Analysis

This article has 12 authors:
1. Roberto Frigerio
2. Angelo Musicò
3. Marco Brucale
4. Andrea Ridolfi
5. Silvia Galbiati
6. Riccardo Vago
7. Greta Bergamaschi
8. Anna Ferretti
9. Marcella Chiari
10. Francesco Valle
11. Alessandro Gori
12. Marina Cretich
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 11, 2020Latest activity Dec 12, 2020
In vitro measurements of protein–protein interactions show that antibody affinity governs the inhibition of SARS-CoV-2 spike/ACE2 binding in convalescent serum

This article has 12 authors:
1. Sebastian Fiedler
2. Monika A. Piziorska
3. Viola Denninger
4. Alexey S. Morgunov
5. Alison Ilsley
6. Anisa Y. Malik
7. Matthias M. Schneider
8. Sean R. A. Devenish
9. Georg Meisl
10. Adriano Aguzzi
11. Heike Fiegler
12. Tuomas P. J. Knowles
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 21, 2020Latest activity Dec 22, 2020

Previous Page 75 of 93 Next

Biochemistry

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M ^pro inhibitor

Fluorescent Glycan Fingerprinting of SARS2 Spike Proteins

No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

Structural characterization of cocktail-like targeting polysaccharides from Ecklonia kurome Okam and their anti-SARS-CoV-2 activities invitro

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

Effect of β-chitosan on the binding interaction between SARS-CoV-2 S-RBD and ACE2

Cryo-EM Structures of the SARS-CoV-2 Endoribonuclease Nsp15

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants

Extracellular Vesicles Analysis in the COVID-19 Era: Insights on Serum Inactivation Protocols Towards Downstream Isolation and Analysis

In vitro measurements of protein–protein interactions show that antibody affinity governs the inhibition of SARS-CoV-2 spike/ACE2 binding in convalescent serum